Literature DB >> 32880639

Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?

Elizabeth C Smyth1, Markus Moehler2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32880639     DOI： 10.1001/jamaoncol.2020.2436

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity in tumor-related genes in gastric cancer.

Authors:  Xueyun Huo; Xiaoqin Xiao; Shuangyue Zhang; Xiaoyan Du; Changlong Li; Zhigang Bai; Zhenwen Chen
Journal:  Oncol Lett       Date:  2021-03-30       Impact factor: 2.967

2.  Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer.

Authors:  Xiaolong Liang; Gangfeng Yu; Lang Zha; Xiong Guo; Anqi Cheng; Chuan Qin; Han Zhang; Ziwei Wang
Journal:  Front Cell Dev Biol       Date:  2022-01-14

3.  Transplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1-/- mice.

Authors:  Tracy L Putoczki; Lorraine A O'Reilly; Jun T Low; Gwo-Yaw Ho; Mark Scott; Chin Wee Tan; Lachlan Whitehead; Kathy Barber; Hon Y K Yip; Johanna F Dekkers; Yumiko Hirokawa; John Silke; Antony W Burgess; Andreas Strasser
Journal:  Cell Death Dis       Date:  2021-11-17       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.